Literature DB >> 31192765

The complexity of serotype replacement of pneumococci.

Orsolya Dobay1.   

Abstract

Pneumococci respond extremely rapidly to the vaccine pressure created by the conjugate vaccines (PCVs). Vaccine serotypes are disappearing, meanwhile new, often previously very rare types are emerging, and it is difficult to establish what makes certain serotypes more successful in replacement. The situation is very complex: every serotype has different antibiotic sensitivity or invasive capacity. However, despite this dynamic serotype rearrangement, the overall pneumococcal carriage rate remains quite stable, suggesting that these bacterial species can be considered as a commensal colonizer.

Entities:  

Keywords:  IPD; Pneumococcal conjugate vaccines; antibiotic resistance; carriage; serotypes

Mesh:

Substances:

Year:  2019        PMID: 31192765      PMCID: PMC6930049          DOI: 10.1080/21645515.2019.1621068

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  16 in total

1.  Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden.

Authors:  Ann Lindstrand; Ilias Galanis; Jessica Darenberg; Eva Morfeldt; Pontus Naucler; Margareta Blennow; Tobias Alfvén; Birgitta Henriques-Normark; Åke Örtqvist
Journal:  Vaccine       Date:  2016-07-26       Impact factor: 3.641

Review 2.  Streptococcus pneumoniae: transmission, colonization and invasion.

Authors:  Jeffrey N Weiser; Daniela M Ferreira; James C Paton
Journal:  Nat Rev Microbiol       Date:  2018-06       Impact factor: 60.633

Review 3.  Pneumococcal Vaccination Strategies. An Update and Perspective.

Authors:  Andrew C Berical; Drew Harris; Charles S Dela Cruz; Jennifer D Possick
Journal:  Ann Am Thorac Soc       Date:  2016-06

4.  Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: Comparison of carried and clinical pneumococcal isolates from the same time period in Hungary.

Authors:  Eszter Kovács; Judit Sahin-Tóth; Adrienn Tóthpál; Katalin Kristóf; Mark van der Linden; Tamás Tirczka; Orsolya Dobay
Journal:  Vaccine       Date:  2018-11-22       Impact factor: 3.641

5.  Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance.

Authors:  Matthew R Moore; Ruth Link-Gelles; William Schaffner; Ruth Lynfield; Catherine Lexau; Nancy M Bennett; Susan Petit; Shelley M Zansky; Lee H Harrison; Arthur Reingold; Lisa Miller; Karen Scherzinger; Ann Thomas; Monica M Farley; Elizabeth R Zell; Thomas H Taylor; Tracy Pondo; Loren Rodgers; Lesley McGee; Bernard Beall; James H Jorgensen; Cynthia G Whitney
Journal:  Lancet Infect Dis       Date:  2015-02-03       Impact factor: 25.071

6.  Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands.

Authors:  Astrid A T M Bosch; Marlies A van Houten; Jacob P Bruin; Alienke J Wijmenga-Monsuur; Krzysztof Trzciński; Debby Bogaert; Nynke Y Rots; Elisabeth A M Sanders
Journal:  Vaccine       Date:  2015-12-05       Impact factor: 3.641

7.  Long-term effects of pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis.

Authors:  Judith Spijkerman; Sabine M P J Prevaes; Elske J M van Gils; Reinier H Veenhoven; Jacob P Bruin; Debby Bogaert; Alienke J Wijmenga-Monsuur; Germie P J M van den Dobbelsteen; Elisabeth A M Sanders
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

8.  Effect of Serotype on Pneumococcal Competition in a Mouse Colonization Model.

Authors:  Krzysztof Trzciński; Yuan Li; Daniel M Weinberger; Claudette M Thompson; Derrick Cordy; Andrew Bessolo; Richard Malley; Marc Lipsitch
Journal:  mBio       Date:  2015-09-15       Impact factor: 7.867

9.  Epidemiological analysis of pneumococcal serotype 19A in healthy children following PCV7 vaccination.

Authors:  A Tóthpál; K Laub; S Kardos; T Tirczka; A Kocsis; M VAN DER Linden; O Dobay
Journal:  Epidemiol Infect       Date:  2015-11-09       Impact factor: 4.434

10.  Should Pneumococcal Vaccines Eliminate Nasopharyngeal Colonization?

Authors:  Larry S McDaniel; Edwin Swiatlo
Journal:  mBio       Date:  2016-05-24       Impact factor: 7.867

View more
  3 in total

1.  Pneumococcal Carriage and Antibiotic Resistance in Children Younger than 5 Years in Nouna District, Burkina Faso.

Authors:  Boubacar Coulibaly; Ali Sié; Dramane Kiemde; Nestor Dembélé; Adama Compaore; Ousmane Dabo; Clarisse Dah; Lucienne Ouermi; Vicky Cevallos; Elodie Lebas; Jessica M Brogdon; Jeremy D Keenan; Catherine E Oldenburg
Journal:  Am J Trop Med Hyg       Date:  2020-05-21       Impact factor: 2.345

2.  Validation of Fourier Transform Infrared Spectroscopy for Serotyping of Streptococcus pneumoniae.

Authors:  I Passaris; N Mauder; M Kostrzewa; I Burckhardt; S Zimmermann; N M van Sorge; H-C Slotved; S Desmet; P-J Ceyssens
Journal:  J Clin Microbiol       Date:  2022-06-14       Impact factor: 11.677

3.  Pneumococcal Disease Prevention: Are We on the Right Track?

Authors:  Nicola Principi; Susanna Esposito
Journal:  Vaccines (Basel)       Date:  2021-03-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.